Exane Derivatives
- SEC CIK
- 0001623883
- Latest filing
- Jul 12, 2022
ACAD holding history
Acadia Pharmaceuticals Inc in every 13F filed by Exane Derivatives, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACAD overviewAll 13F holders of ACADFull Q2 2022 holdings
- Shares (Q3 2021)
- 0
- Sold out in Q3 2021
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 1
- Since Q2 2021